Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Technivie (Ombitasvir, Paritaprevir, Ritonavir) for the Treatment of Genotype 4 Chronic Hepatitis C

Drug Name

Technivie (Ombitasvir, Paritaprevir, Ritonavir)

Company / Licensee

AbbVie

Current Indication

Chronic hepatitis C genotype 4 infection

Market Sector

Anti-infectives

Development Status

Approved in the US
Expand

Go Top